Published in CMAJ on May 01, 2001
Safety and efficiency of emergency department assessment of chest discomfort. CMAJ (2004) 2.09
Rising to the challenge: transforming the treatment of ST-segment elevation myocardial infarction. CMAJ (2003) 1.03
Primary angioplasty for ST-segment elevation myocardial infarction: ready for prime time? CMAJ (2003) 0.98
New advances in the management of acute coronary syndromes: 3. The role of catheter-based procedures. CMAJ (2002) 0.97
Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: an international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II. Can J Cardiol (2007) 0.94
An Asian validation of the TIMI risk score for ST-segment elevation myocardial infarction. PLoS One (2012) 0.78
New advances in the management of acute coronary syndromes. CMAJ (2001) 0.75
Troponin assays for coronary syndrome diagnosis. CMAJ (2002) 0.75
Acute coronary syndromes. CMAJ (2004) 0.75
Evaluating the risks of therapies for acute coronary syndromes. CMAJ (2001) 0.75
The waiting game: facing the consequences. CMAJ (2002) 0.75
The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA (2000) 12.86
Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med (1996) 6.92
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med (1997) 6.19
Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med (1997) 6.17
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med (1996) 5.94
A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med (1998) 5.67
Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med (1984) 5.02
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation (2000) 3.61
Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med (1988) 3.03
Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group. Lancet (1996) 2.75
A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators. N Engl J Med (1998) 2.73
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation (1999) 2.59
Missed diagnoses of acute myocardial infarction in the emergency department: results from a multicenter study. Ann Emerg Med (1993) 2.39
Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3,697 patients. Am J Cardiol (1983) 2.18
Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation (1998) 2.09
Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA (1999) 2.08
Clinical features of unrecognized myocardial infarction--silent and symptomatic. Eighteen year follow-up: the Framingham study. Am J Cardiol (1973) 2.06
Patients with suspected myocardial infarction who present with ST depression. Lancet (1993) 2.00
Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators. Circulation (1998) 1.52
Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients. J Am Coll Cardiol (1995) 1.36
Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. J Am Coll Cardiol (1995) 1.10
Coronary bypass surgery for unstable angina. Circulation (1984) 1.00
Angiographic findings in patients with refractory unstable angina according to troponin T status. Circulation (1999) 0.97
Predictors of risk in patients with unstable angina admitted to a district general hospital. Br Heart J (1992) 0.96
Very early risk stratification using combined ECG and biochemical assessment in patients with unstable coronary artery disease (A thrombin inhibition in myocardial ischemia [TRIM] substudy). The TRIM Study Group. Circulation (1998) 0.95
Clinically unrecognized myocardial infarction in the Western Collaborative Group Study. Am J Cardiol (1967) 0.92
Metaanalysis in clinical chemistry: validation of cardiac troponin T as a marker for ischemic heart diseases. Clin Chem (1995) 0.92
ST-segment monitoring with continuous 12-lead ECG improves early risk stratification in patients with chest pain and ECG nondiagnostic of acute myocardial infarction. J Am Coll Cardiol (1999) 0.87
Guidelines for the early management of acute coronary syndromes: focus on antithrombotic and antiplatelet therapy. Can J Cardiol (2000) 0.83
WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal care. Lancet (2001) 6.86
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med (1997) 6.19
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet (1999) 4.36
A randomized trial of psychosocial support during high-risk pregnancies. The Latin American Network for Perinatal and Reproductive Research. N Engl J Med (1992) 3.81
Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med (1980) 3.12
Reduction in intraventricular hemorrhage by elimination of fluctuating cerebral blood-flow velocity in preterm infants with respiratory distress syndrome. N Engl J Med (1985) 2.76
How do researchers influence decision-makers? Case studies of Mexican policies. Health Policy Plan (1999) 2.52
Psychopathology associated with suicidal ideation and attempts among children and adolescents. J Am Acad Child Adolesc Psychiatry (1998) 2.46
Cleavage of Chordin by Xolloid metalloprotease suggests a role for proteolytic processing in the regulation of Spemann organizer activity. Cell (1997) 2.44
An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature (1994) 2.41
Young, gifted.and spurned. Nature (2001) 2.13
Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med (1992) 2.12
Test-retest reliability of the Diagnostic Interview Schedule for Children (DISC 2.1). Parent, child, and combined algorithms. Arch Gen Psychiatry (1995) 2.05
Thrombolysis in unstable angina. Randomized double-blind trial of t-PA and placebo. Circulation (1992) 1.97
"Alone, I wouldn't have known what to do": a qualitative study on social support during labor and delivery in Mexico. Soc Sci Med (1998) 1.92
Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol (1995) 1.71
Inter-regional differences and outcome in unstable angina; analysis of the international ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events. Eur Heart J (2000) 1.71
Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction. The AMI-SK study. Eur Heart J (2002) 1.65
Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial. Circulation (2001) 1.56
Use of synthetic oligoribonucleotides to probe RNA-protein interactions in the MS2 translational operator complex. Nucleic Acids Res (1990) 1.54
Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial. Eur Heart J (1996) 1.52
Efficacy of postoperative blood salvage following total hip arthroplasty in patients with and without deposited autologous units. J Bone Joint Surg Am (2000) 1.51
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. J Am Coll Cardiol (2001) 1.51
A study on maternal mortality in Mexico through a qualitative approach. J Womens Health Gend Based Med (2000) 1.46
Primary breast lymphoma with skin involvement arising in lymphocytic lobulitis. Histopathology (1994) 1.45
Expression of the cystic fibrosis gene in human development. Development (1991) 1.45
Canadian Cardiovascular Society Consensus Conference 2002: Management of heart disease in the elderly patient. Can J Cardiol (2004) 1.44
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial. J Thromb Haemost (2005) 1.42
Outer membrane protein YadA of enteropathogenic yersiniae mediates specific binding to cellular but not plasma fibronectin. Infect Immun (1993) 1.41
Combined radiotherapy and medical immunosuppression in the management of thyroid eye disease. Eye (Lond) (1997) 1.41
The power of information and contraceptive choice in a family planning setting in Mexico. Sex Transm Infect (2000) 1.40
PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction. Can J Cardiol (1996) 1.39
Variations in measured vessel diameters using coronary measurement system. Cathet Cardiovasc Diagn (1996) 1.39
Acute reduction of lipoprotein(a) by tissue-type plasminogen activator. Circulation (1992) 1.39
Prognosis in medically stabilized unstable angina: early Holter ST-segment monitoring compared with predischarge exercise thallium tomography. Ann Intern Med (1990) 1.38
Europe's Mars mission to pay out for Beagle lander. Nature (2001) 1.38
PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. Am J Pathol (1999) 1.36
Cluster randomised trial of an active, multifaceted educational intervention based on the WHO Reproductive Health Library to improve obstetric practices. BJOG (2006) 1.35
The etiology of maternal mortality in developing countries: what do verbal autopsies tell us? Bull World Health Organ (2001) 1.27
Oxford meniscal bearing knee versus the Marmor knee in unicompartmental arthroplasty for arthrosis. A Swedish multicenter survival study. J Arthroplasty (1995) 1.22
Kinetic analysis of integrin-dependent cell adhesion on vitronectin--the inhibitory potential of plasminogen activator inhibitor-1 and RGD peptides. Eur J Biochem (1998) 1.20
Adverse life events and resilience. J Am Acad Child Adolesc Psychiatry (1998) 1.20
Methodologic pitfalls in the determination of genetic anticipation: the case of Crohn disease. Ann Intern Med (2001) 1.17
RGD peptides and monoclonal antibodies, antagonists of alpha(v)-integrin, enter the cells by independent endocytic pathways. Lab Invest (2001) 1.17
Relationship between specific adverse life events and psychiatric disorders. J Abnorm Child Psychol (2001) 1.15
Localization of beta 1-integrins in human cartilage and their role in chondrocyte adhesion to collagen and fibronectin. Exp Cell Res (1993) 1.13
In vivo therapy of malignant melanoma by means of antagonists of alphav integrins. Int J Cancer (2000) 1.11
Multistate outbreak of Escherichia coli O157:H7 infections associated with a national fast-food chain, 2006: a study incorporating epidemiological and food source traceback results. Epidemiol Infect (2010) 1.10
Worldwide patterns of mitochondrial DNA differentiation in the harbor seal (Phoca vitulina). Mol Biol Evol (1996) 1.09
Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudy. J Am Coll Cardiol (2000) 1.08
Impact of health education during pregnancy on behavior and utilization of health resources. Latin American Network for Perinatal and Reproductive Research. Am J Obstet Gynecol (1995) 1.08
Management of relapse after allo-SCT for AML and the role of second transplantation. Bone Marrow Transplant (2009) 1.08
Early stopping of trials. Lancet (1997) 1.06
Comparison of sterilization by tubal ligation and hysterectomy. Surg Gynecol Obstet (1975) 1.06
Pulse oximetry is a poor predictor of hypoxemia in stable children with sickle cell disease. Arch Pediatr Adolesc Med (2000) 1.05
Vitamin profile of 174 mothers and newborns at parturition. Am J Clin Nutr (1975) 1.05
Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort study. Int J Clin Pract (2012) 1.05
Detection of varicella-zoster virus in lymphocytes by DNA hybridization. J Med Virol (1987) 1.04
Intrauterine diagnosis: potential complications. Am J Obstet Gynecol (1973) 1.04
Telescope retainers for removable partial dentures. J Prosthet Dent (1981) 1.03
A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides. J Exp Med (1994) 1.02
The effect of a perioperative clinical pathway for knee replacement surgery on hospital costs. Anesth Analg (1998) 1.02
Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers. Bone Marrow Transplant (2012) 1.00
The influence of ageing and exercise on tendon growth and degeneration--hypotheses for the initiation and prevention of strain-induced tendinopathies. Comp Biochem Physiol A Mol Integr Physiol (2002) 1.00
Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation. Bone Marrow Transplant (1997) 1.00
Considerations in the development of the automatic implantable defibrillator. Med Instrum (1976) 1.00
Registered nurses' experiences with an evidence-based home care pathway for myocardial infarction clients. Can J Cardiovasc Nurs (2004) 0.99
Effect of individualizing starting doses of a statin according to baseline LDL-cholesterol levels on achieving cholesterol targets: the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study. Atherosclerosis (2006) 0.99
Tooth-supported telescopic prostheses in compromised dentitions: a clinical report. J Prosthet Dent (2000) 0.98
Postpartum hemorrhage in developing countries: is the public health community using the right tools? Int J Gynaecol Obstet (2004) 0.98
Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus. J Am Coll Cardiol (1995) 0.97
Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. Circulation (2000) 0.97
Intermittent micromotion inhibits bone ingrowth. Titanium implants in rabbits. Acta Orthop Scand (1992) 0.96
Pulmonary hemorrhage complicating a typical hemolytic-uremic syndrome. Respiration (2004) 0.96
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events. Am J Cardiol (1998) 0.95
Murine monoclonal antibodies to the myelin-associated glycoprotein react with large granular lymphocytes of human blood. Proc Natl Acad Sci U S A (1985) 0.94
Purtscher's-like retinopathy in chronic renal failure. Ophthalmology (1992) 0.93
Combined magnification endoscopy with chromoendoscopy in the evaluation of patients with suspected malabsorption. Gastrointest Endosc (1997) 0.92
Telescope retainers and their clinical application. J Prosthet Dent (1980) 0.92
Prognostic implications of hyperglycaemia in paediatric head injury. Childs Nerv Syst (1998) 0.92
[Perinatal health in Mexico]. Salud Publica Mex (1988) 0.92
Reduction of the cesarean delivery rate in Ecuador. Int J Gynaecol Obstet (2000) 0.92
Adrenergic blockade. A new approach to hyperthyroidism during pregnancy. Obstet Gynecol (1974) 0.91
IGF-1 and bFGF reduce glutaric acid and 3-hydroxyglutaric acid toxicity in striatal cultures. J Inherit Metab Dis (2001) 0.91
Usefulness of ischemic response to mental stress in predicting silent myocardial ischemia during ambulatory monitoring. Am J Cardiol (1995) 0.91
The intrauterine contraceptive device. A prospective 5 year clinical study. Am J Obstet Gynecol (1972) 0.90
CT appearances of relapse of lymphoma in the lung. Clin Radiol (1990) 0.89
Pathophysiology and time course of silent myocardial ischaemia during mental stress: clinical, anatomical, and physiological correlates. Br Heart J (1995) 0.89
Chronic antigen-specific immune-system activation may potentially be involved in the loosening of cemented acetabular components. J Biomed Mater Res (2001) 0.89
Knee arthroplasty in rheumatoid arthritis. A report from the Swedish Knee Arthroplasty Register on 4,381 primary operations 1985-1995. Acta Orthop Scand (1997) 0.89
A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. Am J Clin Nutr (2001) 0.89
Interrelation of the renin system and erythropoietin in rats. J Lab Clin Med (1980) 0.88
Comparison of primary coronary angioplasty versus thrombolysis in patients with ST-segment elevation acute myocardial infarction and grade II and grade III myocardial ischemia on the enrollment electrocardiogram. Am J Cardiol (2001) 0.87
Blood gas measurements in the kyphoscoliotic gravida and her fetus: Report of a case. Am J Obstet Gynecol (1975) 0.87
A controlled study of vigabatrin and visual abnormalities. Br J Ophthalmol (2000) 0.86